Presentation is loading. Please wait.

Presentation is loading. Please wait.

Long-Term Outcome Of Acute Promyelocytic Leukemia (APL) With Lower Initial Leukocyte Counts By Using All-Trans Retinoic Acid (ATRA) Alone For Remission.

Similar presentations


Presentation on theme: "Long-Term Outcome Of Acute Promyelocytic Leukemia (APL) With Lower Initial Leukocyte Counts By Using All-Trans Retinoic Acid (ATRA) Alone For Remission."— Presentation transcript:

1 Long-Term Outcome Of Acute Promyelocytic Leukemia (APL) With Lower Initial Leukocyte Counts By Using All-Trans Retinoic Acid (ATRA) Alone For Remission Induction Therapy: Japan Adult Leukemia Study Group (JALSG) APL97 Study by Takaaki Ono, Akihiro Takeshita, Katsuji Shinagawa, Yuji Kishimoto, Hitoshi Kiyoi, Masaya Okada, Takahiro Yamauchi, Nobuhiko Emi, Hiroyuki Fujita, Mitsuhiro Matsuda, Fumihiko Monma, Shigeki Ohtake, Chiaki Nakaseko, Masatomo Takahashi, Yukihiko Kimura, Masako Iwanaga, Norio Asou, and Tomoki Naoe Blood Volume 122(21): November 15, 2013 ©2013 by American Society of Hematology

2 Akihiro Takeshita et al. Blood 2013;122:3950
©2013 by American Society of Hematology

3 Akihiro Takeshita et al. Blood 2013;122:3950
©2013 by American Society of Hematology


Download ppt "Long-Term Outcome Of Acute Promyelocytic Leukemia (APL) With Lower Initial Leukocyte Counts By Using All-Trans Retinoic Acid (ATRA) Alone For Remission."

Similar presentations


Ads by Google